Analysis results from the second server showed that the expression of CHD1L influenced negatively OS and distant metastasis-free survival (DMFS) (p < 0.05) (Figure 4A) but not relapse-free survival (RFS) in breast cancer patients. This evidence concerns the gene CHD1L and breast carcinoma.